1
Enquiry period
with 05.08.2021 16:10
to 09.09.2021 15:36
2
Bidding period
with 09.09.2021 15:36
to 02.10.2021 15:36
3
Auction

4
Evaluation
5
Bids have been evaluated
Status Active
Estimated value without VAT 171 505 MDL
Period of clarifications: 5 Aug 2021, 16:10 - 9 Sep 2021, 15:36
Submission of proposals: 9 Sep 2021, 15:36 - 2 Oct 2021, 15:36
Auction start date: will not be used

Supplier technical support:

(+373) 79999801


This procedure is carried out without auction. Your offer is final and must contain the entire list of required documents.

104. Vacutainer, K3 EDTA (3,6 mg, 2ml)
Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, mun.Chişinău, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Full name
Sergiu Balta
Contact phone
+ 373 022 222 364
Purchase data
Date created
5 Aug 2021, 16:05
Date modified
26 Aug 2021, 12:03
Estimated value (without VAT)
171 505 MDL
Achizitii.md ID
21042823
Type of procedure
Open tender
Award criteria
The lowest price
Delivery address
MD-2009, MOLDOVA, mun.Chişinău, mun.Chişinău, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Contract period
1 Jan 2022 02:00 - 31 Dec 2022 02:00
List of positions
1)
Title
104. Vacutainer, K3 EDTA (3,6 mg, 2ml) CPV: 33100000-1 - Medical equipments
Quantity: 343010.0
Unit of measurement: Bucata
Documents of the procurement procedure
duae_ro_0 (1).doc
Bidding Documents
-
5.08.21 16:10
model-contract.doc
Bidding Documents
-
24.08.21 10:38
lista de distributie consumabile laborator 2022 23.08.2021.xlsx
Bidding Documents
-
26.08.21 12:03
Anunț de participare 08.09.2021.pdf
Bidding Documents
-
9.09.21 00:28
formularele-f4.1-si-f4.2-lp 07.09.2021.xlsx
Bidding Documents
-
9.09.21 00:28
caiet de sarcini.semnat.pdf
Bidding Documents
-
9.09.21 00:28

The offers of the participants are available below, you can view the documents for the offers by clicking on the folder icon.

Based on the Working Group Decision, the selection of a winner requires:

1) Choose winner by clicking the button "Winner.”

2) Отправить в течении 3 дней на почту AAP bap@tender.gov.md отсканированное решение рабочей группы.

4) After choosing the winner, press the button: "Confirm"..

Qualification
Participant(s) name(s)
Normalized price
Status
1
Participant(s) name(s):

DITA ESTFARM S.R.L

Normalized price: 257 600,51 MDL
Status: Cancelled
Reason: The bid is unacceptable
Qualification documents
Documents provided with the proposal
2
Participant(s) name(s):

Ecochimie

Normalized price: 332 719,70 MDL
Status: Cancelled
Reason: The bid is unacceptable
Qualification documents
Documents provided with the proposal
3
Participant(s) name(s):

LifeMed Group SRL

Normalized price: 342 152,48 MDL
Status: Cancelled
Reason: The bid is irregular
Qualification documents
Documents provided with the proposal
4
Participant(s) name(s):

ICS "Farmina" SRL

Normalized price: 391 031,40 MDL
Status: Cancelled
Reason: The bid is unacceptable
Qualification documents
Documents provided with the proposal
The history of the auction
View auction
104. Vacutainer, K3 EDTA (3,6 mg, 2ml)
Date:
12 Aug 2021, 18:02
Question's name:
Clarificare
Question:
Rugam sa argumentati motivul indicarii K3 EDTA (3,6 mg). Consideram ca aceasta cerinta standarda a bunului va crea impedimente in evaluarea ofertelor din motiv ca cantitatea de K3 EDTA nu se indica de producatori in catalog. Doar un singur producator reflecta acest parametru in catalogul sau. Este o cerinta restrictiva daca se va insista la demonstrarea corespunderii acestui parametru doar in baza informatiei din catalog. In documentele tehnice suplimentare aceasta cerinta se poate regasi la toti producatorii. Rugam sa clarificati daca vor fi acceptate documente suplimentare pentru demonstrarea conformitatii bunului oferit cu specificatia tehnica solicitata.
Answer (13 Aug 2021, 12:19):
Da, se vor accepta la evaluare și documente suplimentare autorizate de către producător prin care se va demostra corespunderea bunurilor oferite
Unfortunately, questions can be asked only during the "Active" period.
Clarifications